A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Condition(s):IgA Nephropathy; Focal Segmental GlomerulosclerosisLast Updated:July 14, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):IgA Nephropathy; Focal Segmental GlomerulosclerosisLast Updated:July 14, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:March 14, 2022Not yet recruiting
Condition(s):Healthy SubjectsLast Updated:October 17, 2023Recruiting
Condition(s):Paroxysmal Nocturnal Hemoglobinuria (PNH)Last Updated:November 18, 2023Recruiting
Condition(s):Chronic Pain; Chronic Pain Syndrome; Chronic Pancreatitis; Hyperalgesia; Opioid Use Disorder; Opioid-Related Disorders; Opioid Dependence; Chronic Abdominal Pain; ERCP; Pancreatic SurgeryLast Updated:September 25, 2023Recruiting
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:November 18, 2023Not yet recruiting
Condition(s):GlioblastomaLast Updated:July 7, 2023Recruiting
Condition(s):Cataract; Endothelial Cell Loss, CornealLast Updated:December 2, 2022Recruiting
Condition(s):Cytomegalovirus (CMV)Last Updated:March 12, 2024Recruiting
Condition(s):Glioma, MalignantLast Updated:January 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.